FDA approves injectable diabetes drug from Glaxo

Published



WASHINGTON (AP) — The Food and Drug Administration said Tuesday it approved a new injectable drug from GlaxoSmithKline plc for adults with Type 2 diabetes.

The agency cleared the company’s drug, Tanzeum, to help patients control their blood sugar levels, in combination with diet and exercise.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.